Amyris Fights Claims In Cannabis IP Row By Defining 'Under'

By Alex Wittenberg · January 9, 2024, 7:42 PM EST

Biotechnology company Amyris Inc. said Tuesday the word "under" in a contract between it and cannabinoid manufacturer Lavvan supports its effort to quash two claims Lavvan has filed against the debtor,...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

Synthesized biologicals producer Amyris filed for Chapter 11 bankruptcy protection in August with more than $1.1 billion in debt and plans to sell parts of its business. It received court approval of its $190 million debtor-in-possession loan.

Case Number

1:23-bk-11131

Judge

Thomas M. Horan

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$1.1 billion

View Full Scorecard

Documents

Related Sections

Case Information

Case Title

Amyris, Inc.

Case Number

1:23-bk-11131

Court

Delaware

Nature of Suit

Date Filed

August 09, 2023

Recent Articles By Alex